BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28364926)

  • 1. Transforming vaccines supply chains in Nigeria.
    Sarley D; Mahmud M; Idris J; Osunkiyesi M; Dibosa-Osadolor O; Okebukola P; Wiwa O
    Vaccine; 2017 Apr; 35(17):2167-2174. PubMed ID: 28364926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving cold chain systems: Challenges and solutions.
    Ashok A; Brison M; LeTallec Y
    Vaccine; 2017 Apr; 35(17):2217-2223. PubMed ID: 27670076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reorganizing Nigeria's Vaccine Supply Chain Reduces Need For Additional Storage Facilities, But More Storage Is Required.
    Shittu E; Harnly M; Whitaker S; Miller R
    Health Aff (Millwood); 2016 Feb; 35(2):293-300. PubMed ID: 26858383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming cold chain performance and management in lower-income countries.
    Brison M; LeTallec Y
    Vaccine; 2017 Apr; 35(17):2107-2109. PubMed ID: 28364916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the policy environment for immunization supply chains: Lessons learned from landscape analyses in Uganda and Senegal.
    Luzze H; Badiane O; Mamadou Ndiaye EH; Ndiaye AS; Atuhaire B; Atuhebwe P; Guinot P; Fry Sosne E; Gueye A
    Vaccine; 2017 Apr; 35(17):2141-2147. PubMed ID: 28364922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary results from direct-to-facility vaccine deliveries in Kano, Nigeria.
    Aina M; Igbokwe U; Jegede L; Fagge R; Thompson A; Mahmoud N
    Vaccine; 2017 Apr; 35(17):2175-2182. PubMed ID: 28364927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine vial monitor availability and use in low- and middle-income countries: A systematic review.
    Eriksson P; Gessner BD; Jaillard P; Morgan C; Le Gargasson JB
    Vaccine; 2017 Apr; 35(17):2155-2161. PubMed ID: 28364924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Building Strong Health Supply Chain Systems: The Visibility and Analytics Network approach to improving the Nigeria Immunization Supply Chain.
    Ottih C; Cussen K; Mustafa M
    J Innov Health Inform; 2018 Dec; 25(4):199-206. PubMed ID: 30672401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seizing market shaping opportunities for vaccine cold chain equipment.
    Azimi T; Franzel L; Probst N
    Vaccine; 2017 Apr; 35(17):2260-2264. PubMed ID: 28364940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a pilot intervention to redesign the decentralised vaccine supply chain system in Nigeria.
    Molemodile S; Wotogbe M; Abimbola S
    Glob Public Health; 2017 May; 12(5):601-616. PubMed ID: 28278748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of vaccine supply chains with other health commodity supply chains: a framework for decision making.
    Yadav P; Lydon P; Oswald J; Dicko M; Zaffran M
    Vaccine; 2014 Nov; 32(50):6725-32. PubMed ID: 25446826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using solar-powered refrigeration for vaccine storage where other sources of reliable electricity are inadequate or costly.
    McCarney S; Robertson J; Arnaud J; Lorenson K; Lloyd J
    Vaccine; 2013 Dec; 31(51):6050-7. PubMed ID: 23933340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating scenarios of locations and capacities for vaccine storage in Nigeria.
    Hirsh Bar Gai D; Graybill Z; Voevodsky P; Shittu E
    Vaccine; 2018 Jun; 36(24):3505-3512. PubMed ID: 29773321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equity and immunization supply chain in Madagascar.
    van den Ent MMVX; Yameogo A; Ribaira E; Hanson CM; Ratoto R; Rasolomanana S; Foncha C; Gasse F
    Vaccine; 2017 Apr; 35(17):2148-2154. PubMed ID: 28364923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The origins of the vaccine cold chain and a glimpse of the future.
    Lloyd J; Cheyne J
    Vaccine; 2017 Apr; 35(17):2115-2120. PubMed ID: 28364918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Going national with EPI in Nigeria.
    Reid RS; Smith EA
    Assignment Child; 1984; (65-68):179-205. PubMed ID: 12266655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. System redesign of the immunization supply chain: Experiences from Benin and Mozambique.
    Prosser W; Jaillard P; Assy E; Brown ST; Matsinhe G; Dekoun M; Lee BY
    Vaccine; 2017 Apr; 35(17):2162-2166. PubMed ID: 28364925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Making the leap into the next generation: A commentary on how Gavi, the Vaccine Alliance is supporting countries' supply chain transformations in 2016-2020.
    Brooks A; Habimana D; Huckerby G
    Vaccine; 2017 Apr; 35(17):2110-2114. PubMed ID: 28364917
    [No Abstract]   [Full Text] [Related]  

  • 19. Country ownership and sustainability of Nigeria's HIV/AIDS Supply Chain System: qualitative perceptions of progress, challenges and prospects.
    Itiola AJ; Agu KA
    J Pharm Policy Pract; 2018; 11():21. PubMed ID: 30214814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Root cause analysis underscores the importance of understanding, addressing, and communicating cold chain equipment failures to improve equipment performance.
    Lennon P; Atuhaire B; Yavari S; Sampath V; Mvundura M; Ramanathan N; Robertson J
    Vaccine; 2017 Apr; 35(17):2198-2202. PubMed ID: 28364931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.